GMOI - ETF AI Analysis
Top Page
GMO International Value ETF (GMOI)
GMOI (GMO International Value ETF) has a solid overall rating, suggesting it holds a generally attractive mix of international value stocks with reasonable quality and return potential. Strong contributors like Rio Tinto, GSK, and major financial names such as BNP Paribas and Manulife Financial support the fund through solid profitability, attractive valuations, and healthy dividends. The main risk is its heavy tilt toward financials and energy-related companies, which can make the ETF more sensitive to sector-specific and regional economic challenges.
GMOI vs. SPDR S&P 500 ETF (SPY)
- AUM
- 680.36M
- Region
- Global
- Expense Ratio
- 0.60%
- Beta
- 0.58
- Issuer
- GMO
- Inception Date
- Oct 28, 2024
- Dividend Yield
- 2.66%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
GMOI Summary
GMO International Value ETF (GMOI) is a global stock fund that follows a value theme, aiming to invest in companies that appear cheap compared with their business fundamentals. It does not track a specific index, but instead uses GMO’s research to pick undervalued companies across many countries and sectors. Well-known holdings include BNP Paribas and TotalEnergies. Investors might consider GMOI for long-term growth and diversification beyond the U.S. market. A key risk is that value stocks can stay out of favor for long periods, and the ETF’s price can go up and down with global markets.
How much will it cost me?
The GMO International Value ETF has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on identifying undervalued international companies using detailed research and analysis.
What would affect this ETF?
The GMO International Value ETF could benefit from global economic recovery, which may increase demand for undervalued stocks in sectors like Financials and Industrials, where it has significant exposure. However, rising interest rates or geopolitical tensions could negatively impact its holdings, particularly in financial institutions and energy companies. Its global diversification offers resilience, but currency fluctuations and regional economic instability may pose risks.
GMOI Top 10 Holdings
GMO International Value leans heavily on global financials and energy, with European banks and oil majors steering the ship. Equinor and TotalEnergies have been rising and look like key engines for recent gains, while Rio Tinto’s more mixed performance adds a cyclical twist from the materials side. Canadian banks like Bank of Nova Scotia and TD are steady contributors, though BNP Paribas and BBVA show more of a stop‑and‑go pattern. Health care names such as Sanofi and GSK have been lagging, slightly dragging on an otherwise globally diversified, value‑tilted portfolio.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 FR:TTE | TotalEnergies SE | 3.77% | $25.56M | EUR 179.76B | 52.27% | 78Outperform |
 TSE:BNS | Bank Of Nova Scotia | 3.46% | $23.46M | CAD 158.37B | 44.41% | 77Outperform |
 FR:BNP | BNP Paribas | 2.84% | $19.29M | EUR 96.47B | 25.83% | 77Outperform |
 RIO | Rio Tinto | 2.86% | $19.38M | $153.22B | 27.33% | 80Outperform |
 JP:9432 | Nippon Telegraph and Telephone | 2.63% | $17.84M | JPY 14.92T | 11.38% | 73Outperform |
 EQNR | Equinor ASA | 2.48% | $16.85M | $110.64B | 97.50% | 69Neutral |
 GSK | GlaxoSmithKline | 2.41% | $16.35M | $99.40B | 14.76% | 77Outperform |
 SNY | Sanofi | 2.30% | $15.63M | $95.62B | -16.75% | 75Outperform |
 TSE:MFC | Manulife Financial | 2.21% | $14.97M | CAD 103.30B | 39.86% | 79Outperform |
 BBVA | Banco Bilbao | 2.13% | $14.43M | $140.01B | 26.69% | 76Outperform |
GMOI Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GMOI, the sentiment is Positive. The current price of 40.27 is above the 20-day moving average (MA) of 39.71, below the 50-day MA of 40.65, and above the 200-day MA of 38.03, indicating a neutral trend. The MACD of -0.20 indicates Negative momentum. The RSI at 54.06 is Neutral, neither overbought nor oversold. The STOCH value of 79.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GMOI.
GMOI Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| GMOI | $40.27 | $43.00(6.78% Upside) | $680.36M | 0.60% | 67Neutral |
 FPAG | $42.06 | $48.01(14.16% Upside) | $645.09M | 0.49% | 60Neutral |
 MFSV | $29.50 | $33.67(14.15% Upside) | $634.04M | 0.44% | 72Outperform |
 BINV | $44.97 | $52.18(16.03% Upside) | $546.81M | 0.70% | 58Neutral |
 COPY | $15.68 | $17.62(12.35% Upside) | $420.31M | 0.80% | 58Neutral |
 PJFV | $101.04 | $116.13(14.93% Upside) | $197.14M | 0.33% | 70Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GMOI | GMO International Value ETF | 40.27 | 9.49 | 30.82% | |
| FPAG | FPA Global Equity ETF | 42.06 | 6.42 | 18.03% | |
| MFSV | MFS Active Value ETF | 29.50 | 3.84 | 14.94% | |
| BINV | Brandes International ETF | 44.97 | 6.80 | 17.83% | |
| COPY | Tweedy Browne Insider + Value ETF Trust Units | 15.68 | 3.50 | 28.69% | |
| PJFV | PGIM Jennison Focused Value ETF | 101.04 | 21.28 | 26.68% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.